Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence.
Lázničková P, Kepák T, Hortová-Kohoutková M, Horváth L, Sheardová K, Marciniak R, Vacca C, Šiklová M, Zelante T, Rossmeislová L, Křenová Z, Štěrba J, Bendíčková K, Frič J.
Lázničková P, et al. Among authors: fric j.
Eur J Immunol. 2020 Dec;50(12):2092-2094. doi: 10.1002/eji.202048541. Epub 2020 Aug 18.
Eur J Immunol. 2020.
PMID: 32744364
Free PMC article.